APO Research
Talk to an analyst

APO RESEARCH · REPORT

Iodine Contrast Agent Intermediate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Iodine Contrast Agent Intermediate Market Outlook and Growth Opportunities 2026

8 January 2026194 pages

Choose your research edition.

Industry ResearchIodine Contrast Agent Intermediate Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Iodine Contrast Agent Intermediate Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Iodine Contrast Agent Intermediate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Iodine Contrast Agent Intermediate Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Iodine Contrast Agent Intermediate Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Iodine Contrast Agent Intermediate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Iodine Contrast Agent Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Iodine Contrast Agent Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Iodine Contrast Agent Intermediate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Iodine Contrast Agent Intermediate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Iodine Contrast Agent Intermediate market include Brother Technology, Stellite, Shandong Boyuan Pharmaceutical Chemistry, Hokuriku Pharmaceutical, Otsuka Chemicals, Guerbet Group, GE Healthcare, Bracco Imaging and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Iodine Contrast Agent Intermediate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Iodine Contrast Agent Intermediate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Iodine Contrast Agent Intermediate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Iodine Contrast Agent Intermediate market size, projected growth trends, production technologies, key applications, and end-use industries.

Iodine Contrast Agent Intermediate Segment by Company

Brother Technology

Stellite

Shandong Boyuan Pharmaceutical Chemistry

Hokuriku Pharmaceutical

Otsuka Chemicals

Guerbet Group

GE Healthcare

Bracco Imaging

Bayer

Iodine Contrast Agent Intermediate Segment by Type

Iohexol Hydrolysate

Triiodoisophthaloyl Chloride

Iohexyl Iodide

Other

Iodine Contrast Agent Intermediate Segment by Application

Iopromide

Iopamidol

Iomeprol

Iodixanol

Iohexol

Ioversol

Iodine Contrast Agent Intermediate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Iodine Contrast Agent Intermediate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Iodine Contrast Agent Intermediate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Iodine Contrast Agent Intermediate significant trends, drivers, influence factors in global and regions.

6. To analyze Iodine Contrast Agent Intermediate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Iodine Contrast Agent Intermediate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Iodine Contrast Agent Intermediate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Iodine Contrast Agent Intermediate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Iodine Contrast Agent Intermediate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Iodine Contrast Agent Intermediate industry.

Chapter 3: Detailed analysis of Iodine Contrast Agent Intermediate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Iodine Contrast Agent Intermediate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Iodine Contrast Agent Intermediate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Iodine Contrast Agent Intermediate Industry Trends Table 2. Iodine Contrast Agent Intermediate Industry Drivers Table 3. Iodine Contrast Agent Intermediate Industry Opportunities and Challenges Table 4. Iodine Contrast Agent Intermediate Industry Restraints Table 5. Global Iodine Contrast Agent Intermediate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Iodine Contrast Agent Intermediate Revenue Share by Company (2021-2026) Table 7. Global Iodine Contrast Agent Intermediate Sales Volume by Company (t) & (2021-2026) Table 8. Global Iodine Contrast Agent Intermediate Sales Volume Share by Company (2021-2026) Table 9. Global Iodine Contrast Agent Intermediate Average Price (USD/t) of Company (2021-2026) Table 10. Global Iodine Contrast Agent Intermediate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Iodine Contrast Agent Intermediate Key Company Manufacturing Base & Headquarters Table 12. Global Iodine Contrast Agent Intermediate Company, Product Type & Application Table 13. Global Iodine Contrast Agent Intermediate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Iodine Contrast Agent Intermediate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Iohexol Hydrolysate Table 18. Significant Companies of Triiodoisophthaloyl Chloride Table 19. Significant Companies of Iohexyl Iodide Table 20. Significant Companies of Other Table 21. Global Iodine Contrast Agent Intermediate Sales Volume by Type 2021 VS 2025 VS 2032 (t) Table 22. Global Iodine Contrast Agent Intermediate Sales Volume by Type (2021-2026) & (t) Table 23. Global Iodine Contrast Agent Intermediate Sales Volume by Type (2027-2032) & (t) Table 24. Global Iodine Contrast Agent Intermediate Sales Volume Share by Type (2021-2026) Table 25. Global Iodine Contrast Agent Intermediate Sales Volume Share by Type (2027-2032) Table 26. Global Iodine Contrast Agent Intermediate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Iodine Contrast Agent Intermediate Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Iodine Contrast Agent Intermediate Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Iodine Contrast Agent Intermediate Sales Value Share by Type (2021-2026) Table 30. Global Iodine Contrast Agent Intermediate Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Iopromide Table 32. Significant Companies of Iopamidol Table 33. Significant Companies of Iomeprol Table 34. Significant Companies of Iodixanol Table 35. Significant Companies of Iohexol Table 36. Significant Companies of Ioversol Table 37. Global Iodine Contrast Agent Intermediate Sales Volume by Application 2021 VS 2025 VS 2032 (t) Table 38. Global Iodine Contrast Agent Intermediate Sales Volume by Application (2021-2026) & (t) Table 39. Global Iodine Contrast Agent Intermediate Sales Volume by Application (2027-2032) & (t) Table 40. Global Iodine Contrast Agent Intermediate Sales Volume Share by Application (2021-2026) Table 41. Global Iodine Contrast Agent Intermediate Sales Volume Share by Application (2027-2032) Table 42. Global Iodine Contrast Agent Intermediate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Iodine Contrast Agent Intermediate Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Iodine Contrast Agent Intermediate Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Iodine Contrast Agent Intermediate Sales Value Share by Application (2021-2026) Table 46. Global Iodine Contrast Agent Intermediate Sales Value Share by Application (2027-2032) Table 47. Global Iodine Contrast Agent Intermediate Sales by Region: 2021 VS 2025 VS 2032 (t) Table 48. Global Iodine Contrast Agent Intermediate Sales by Region (2021-2026) & (t) Table 49. Global Iodine Contrast Agent Intermediate Sales Market Share by Region (2021-2026) Table 50. Global Iodine Contrast Agent Intermediate Sales by Region (2027-2032) & (t) Table 51. Global Iodine Contrast Agent Intermediate Sales Market Share by Region (2027-2032) Table 52. Global Iodine Contrast Agent Intermediate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Iodine Contrast Agent Intermediate Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Iodine Contrast Agent Intermediate Sales Value Share by Region (2021-2026) Table 55. Global Iodine Contrast Agent Intermediate Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Iodine Contrast Agent Intermediate Sales Value Share by Region (2027-2032) Table 57. Global Iodine Contrast Agent Intermediate Market Average Price (USD/t) by Region (2021-2026) Table 58. Global Iodine Contrast Agent Intermediate Market Average Price (USD/t) by Region (2027-2032) Table 59. Global Iodine Contrast Agent Intermediate Sales by Country: 2021 VS 2025 VS 2032 (t) Table 60. Global Iodine Contrast Agent Intermediate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Iodine Contrast Agent Intermediate Sales by Country (2021-2026) & (t) Table 62. Global Iodine Contrast Agent Intermediate Sales Market Share by Country (2021-2026) Table 63. Global Iodine Contrast Agent Intermediate Sales by Country (2027-2032) & (t) Table 64. Global Iodine Contrast Agent Intermediate Sales Market Share by Country (2027-2032) Table 65. Global Iodine Contrast Agent Intermediate Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Iodine Contrast Agent Intermediate Sales Value Market Share by Country (2021-2026) Table 67. Global Iodine Contrast Agent Intermediate Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Iodine Contrast Agent Intermediate Sales Value Market Share by Country (2027-2032) Table 69. Brother Technology Company Information Table 70. Brother Technology Business Overview Table 71. Brother Technology Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 72. Brother Technology Iodine Contrast Agent Intermediate Product Portfolio Table 73. Brother Technology Recent Development Table 74. Stellite Company Information Table 75. Stellite Business Overview Table 76. Stellite Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 77. Stellite Iodine Contrast Agent Intermediate Product Portfolio Table 78. Stellite Recent Development Table 79. Shandong Boyuan Pharmaceutical Chemistry Company Information Table 80. Shandong Boyuan Pharmaceutical Chemistry Business Overview Table 81. Shandong Boyuan Pharmaceutical Chemistry Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 82. Shandong Boyuan Pharmaceutical Chemistry Iodine Contrast Agent Intermediate Product Portfolio Table 83. Shandong Boyuan Pharmaceutical Chemistry Recent Development Table 84. Hokuriku Pharmaceutical Company Information Table 85. Hokuriku Pharmaceutical Business Overview Table 86. Hokuriku Pharmaceutical Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 87. Hokuriku Pharmaceutical Iodine Contrast Agent Intermediate Product Portfolio Table 88. Hokuriku Pharmaceutical Recent Development Table 89. Otsuka Chemicals Company Information Table 90. Otsuka Chemicals Business Overview Table 91. Otsuka Chemicals Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 92. Otsuka Chemicals Iodine Contrast Agent Intermediate Product Portfolio Table 93. Otsuka Chemicals Recent Development Table 94. Guerbet Group Company Information Table 95. Guerbet Group Business Overview Table 96. Guerbet Group Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 97. Guerbet Group Iodine Contrast Agent Intermediate Product Portfolio Table 98. Guerbet Group Recent Development Table 99. GE Healthcare Company Information Table 100. GE Healthcare Business Overview Table 101. GE Healthcare Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 102. GE Healthcare Iodine Contrast Agent Intermediate Product Portfolio Table 103. GE Healthcare Recent Development Table 104. Bracco Imaging Company Information Table 105. Bracco Imaging Business Overview Table 106. Bracco Imaging Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 107. Bracco Imaging Iodine Contrast Agent Intermediate Product Portfolio Table 108. Bracco Imaging Recent Development Table 109. Bayer Company Information Table 110. Bayer Business Overview Table 111. Bayer Iodine Contrast Agent Intermediate Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 112. Bayer Iodine Contrast Agent Intermediate Product Portfolio Table 113. Bayer Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Iodine Contrast Agent Intermediate Distributors List Table 117. Iodine Contrast Agent Intermediate Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Iodine Contrast Agent Intermediate Product Image Figure 2. Global Iodine Contrast Agent Intermediate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Iodine Contrast Agent Intermediate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Iodine Contrast Agent Intermediate Sales (2021-2032) & (t) Figure 5. Global Iodine Contrast Agent Intermediate Sales Average Price (USD/t) & (2021-2032) Figure 6. Global Iodine Contrast Agent Intermediate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Iohexol Hydrolysate Image Figure 10. Triiodoisophthaloyl Chloride Image Figure 11. Iohexyl Iodide Image Figure 12. Other Image Figure 13. Global Iodine Contrast Agent Intermediate Sales Volume by Type (2021 VS 2025 VS 2032) & (t) Figure 14. Global Iodine Contrast Agent Intermediate Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Iodine Contrast Agent Intermediate Sales Volume Share by Type (2021-2032) Figure 16. Global Iodine Contrast Agent Intermediate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Iodine Contrast Agent Intermediate Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Iodine Contrast Agent Intermediate Sales Value Share by Type (2021-2032) Figure 19. Iopromide Image Figure 20. Iopamidol Image Figure 21. Iomeprol Image Figure 22. Iodixanol Image Figure 23. Iohexol Image Figure 24. Ioversol Image Figure 25. Global Iodine Contrast Agent Intermediate Sales Volume by Application (2021 VS 2025 VS 2032) & (t) Figure 26. Global Iodine Contrast Agent Intermediate Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Iodine Contrast Agent Intermediate Sales Volume Share by Application (2021-2032) Figure 28. Global Iodine Contrast Agent Intermediate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Iodine Contrast Agent Intermediate Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Iodine Contrast Agent Intermediate Sales Value Share by Application (2021-2032) Figure 31. Global Iodine Contrast Agent Intermediate Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 32. Global Iodine Contrast Agent Intermediate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Iodine Contrast Agent Intermediate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Iodine Contrast Agent Intermediate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Iodine Contrast Agent Intermediate Sales Value (2021-2032) & (US$ Million) Figure 36. North America Iodine Contrast Agent Intermediate Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Iodine Contrast Agent Intermediate Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Iodine Contrast Agent Intermediate Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Iodine Contrast Agent Intermediate Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Iodine Contrast Agent Intermediate Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Iodine Contrast Agent Intermediate Sales Value (2021-2032) & (US$ Million) Figure 42. South America Iodine Contrast Agent Intermediate Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Iodine Contrast Agent Intermediate Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Iodine Contrast Agent Intermediate Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Iodine Contrast Agent Intermediate Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Iodine Contrast Agent Intermediate Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Iohexol Hydrolysate
  • Triiodoisophthaloyl Chloride
  • Iohexyl Iodide
  • Other
Applications
  • Iopromide
  • Iopamidol
  • Iomeprol
  • Iodixanol
  • Iohexol
  • Ioversol
Companies covered
  • Brother Technology
  • Stellite
  • Shandong Boyuan Pharmaceutical Chemistry
  • Hokuriku Pharmaceutical
  • Otsuka Chemicals
  • Guerbet Group
  • GE Healthcare
  • Bracco Imaging
  • Bayer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Iodine Contrast Agent Intermediate Sales Value (2021-2032)
  4. 1.2.2 Global Iodine Contrast Agent Intermediate Sales Volume (2021-2032)
  5. 1.2.3 Global Iodine Contrast Agent Intermediate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Iodine Contrast Agent Intermediate Market Dynamics
  1. 2.1 Iodine Contrast Agent Intermediate Industry Trends
  2. 2.2 Iodine Contrast Agent Intermediate Industry Drivers
  3. 2.3 Iodine Contrast Agent Intermediate Industry Opportunities and Challenges
  4. 2.4 Iodine Contrast Agent Intermediate Industry Restraints
3 Iodine Contrast Agent Intermediate Market by Company
  1. 3.1 Global Iodine Contrast Agent Intermediate Company Revenue Ranking in 2025
  2. 3.2 Global Iodine Contrast Agent Intermediate Revenue by Company (2021-2026)
  3. 3.3 Global Iodine Contrast Agent Intermediate Sales Volume by Company (2021-2026)
  4. 3.4 Global Iodine Contrast Agent Intermediate Average Price by Company (2021-2026)
  5. 3.5 Global Iodine Contrast Agent Intermediate Company Ranking (2024-2026)
  6. 3.6 Global Iodine Contrast Agent Intermediate Company Manufacturing Base and Headquarters
  7. 3.7 Global Iodine Contrast Agent Intermediate Company Product Type and Application
  8. 3.8 Global Iodine Contrast Agent Intermediate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Iodine Contrast Agent Intermediate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Iodine Contrast Agent Intermediate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Iodine Contrast Agent Intermediate Market by Type
  1. 4.1 Iodine Contrast Agent Intermediate Type Introduction
  2. 4.1.1 Iohexol Hydrolysate
  3. 4.1.2 Triiodoisophthaloyl Chloride
  4. 4.1.3 Iohexyl Iodide
  5. 4.1.4 Other
  6. 4.2 Global Iodine Contrast Agent Intermediate Sales Volume by Type
  7. 4.2.1 Global Iodine Contrast Agent Intermediate Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Iodine Contrast Agent Intermediate Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Iodine Contrast Agent Intermediate Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Iodine Contrast Agent Intermediate Sales Value by Type
  11. 4.3.1 Global Iodine Contrast Agent Intermediate Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Iodine Contrast Agent Intermediate Sales Value by Type (2021-2032)
  13. 4.3.3 Global Iodine Contrast Agent Intermediate Sales Value Share by Type (2021-2032)
5 Iodine Contrast Agent Intermediate Market by Application
  1. 5.1 Iodine Contrast Agent Intermediate Application Introduction
  2. 5.1.1 Iopromide
  3. 5.1.2 Iopamidol
  4. 5.1.3 Iomeprol
  5. 5.1.4 Iodixanol
  6. 5.1.5 Iohexol
  7. 5.1.6 Ioversol
  8. 5.2 Global Iodine Contrast Agent Intermediate Sales Volume by Application
  9. 5.2.1 Global Iodine Contrast Agent Intermediate Sales Volume by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Iodine Contrast Agent Intermediate Sales Volume by Application (2021-2032)
  11. 5.2.3 Global Iodine Contrast Agent Intermediate Sales Volume Share by Application (2021-2032)
  12. 5.3 Global Iodine Contrast Agent Intermediate Sales Value by Application
  13. 5.3.1 Global Iodine Contrast Agent Intermediate Sales Value by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Iodine Contrast Agent Intermediate Sales Value by Application (2021-2032)
  15. 5.3.3 Global Iodine Contrast Agent Intermediate Sales Value Share by Application (2021-2032)
6 Iodine Contrast Agent Intermediate Regional Sales and Value Analysis
  1. 6.1 Global Iodine Contrast Agent Intermediate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Iodine Contrast Agent Intermediate Sales by Region (2021-2032)
  3. 6.2.1 Global Iodine Contrast Agent Intermediate Sales by Region: 2021-2026
  4. 6.2.2 Global Iodine Contrast Agent Intermediate Sales by Region (2027-2032)
  5. 6.3 Global Iodine Contrast Agent Intermediate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Iodine Contrast Agent Intermediate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Iodine Contrast Agent Intermediate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Iodine Contrast Agent Intermediate Sales Value by Region (2027-2032)
  9. 6.5 Global Iodine Contrast Agent Intermediate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Iodine Contrast Agent Intermediate Sales Value (2021-2032)
  12. 6.6.2 North America Iodine Contrast Agent Intermediate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Iodine Contrast Agent Intermediate Sales Value (2021-2032)
  15. 6.7.2 Europe Iodine Contrast Agent Intermediate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Iodine Contrast Agent Intermediate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Iodine Contrast Agent Intermediate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Iodine Contrast Agent Intermediate Sales Value (2021-2032)
  21. 6.9.2 South America Iodine Contrast Agent Intermediate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Iodine Contrast Agent Intermediate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Iodine Contrast Agent Intermediate Sales Value Share by Country, 2025 VS 2032
7 Iodine Contrast Agent Intermediate Country-level Sales and Value Analysis
  1. 7.1 Global Iodine Contrast Agent Intermediate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Iodine Contrast Agent Intermediate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Iodine Contrast Agent Intermediate Sales by Country (2021-2032)
  4. 7.3.1 Global Iodine Contrast Agent Intermediate Sales by Country (2021-2026)
  5. 7.3.2 Global Iodine Contrast Agent Intermediate Sales by Country (2027-2032)
  6. 7.4 Global Iodine Contrast Agent Intermediate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Iodine Contrast Agent Intermediate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Iodine Contrast Agent Intermediate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Iodine Contrast Agent Intermediate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Iodine Contrast Agent Intermediate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Iodine Contrast Agent Intermediate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Brother Technology
  2. 8.1.1 Brother Technology Company Information
  3. 8.1.2 Brother Technology Business Overview
  4. 8.1.3 Brother Technology Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Brother Technology Iodine Contrast Agent Intermediate Product Portfolio
  6. 8.1.5 Brother Technology Recent Developments
  7. 8.2 Stellite
  8. 8.2.1 Stellite Company Information
  9. 8.2.2 Stellite Business Overview
  10. 8.2.3 Stellite Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Stellite Iodine Contrast Agent Intermediate Product Portfolio
  12. 8.2.5 Stellite Recent Developments
  13. 8.3 Shandong Boyuan Pharmaceutical Chemistry
  14. 8.3.1 Shandong Boyuan Pharmaceutical Chemistry Company Information
  15. 8.3.2 Shandong Boyuan Pharmaceutical Chemistry Business Overview
  16. 8.3.3 Shandong Boyuan Pharmaceutical Chemistry Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Boyuan Pharmaceutical Chemistry Iodine Contrast Agent Intermediate Product Portfolio
  18. 8.3.5 Shandong Boyuan Pharmaceutical Chemistry Recent Developments
  19. 8.4 Hokuriku Pharmaceutical
  20. 8.4.1 Hokuriku Pharmaceutical Company Information
  21. 8.4.2 Hokuriku Pharmaceutical Business Overview
  22. 8.4.3 Hokuriku Pharmaceutical Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hokuriku Pharmaceutical Iodine Contrast Agent Intermediate Product Portfolio
  24. 8.4.5 Hokuriku Pharmaceutical Recent Developments
  25. 8.5 Otsuka Chemicals
  26. 8.5.1 Otsuka Chemicals Company Information
  27. 8.5.2 Otsuka Chemicals Business Overview
  28. 8.5.3 Otsuka Chemicals Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Otsuka Chemicals Iodine Contrast Agent Intermediate Product Portfolio
  30. 8.5.5 Otsuka Chemicals Recent Developments
  31. 8.6 Guerbet Group
  32. 8.6.1 Guerbet Group Company Information
  33. 8.6.2 Guerbet Group Business Overview
  34. 8.6.3 Guerbet Group Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guerbet Group Iodine Contrast Agent Intermediate Product Portfolio
  36. 8.6.5 Guerbet Group Recent Developments
  37. 8.7 GE Healthcare
  38. 8.7.1 GE Healthcare Company Information
  39. 8.7.2 GE Healthcare Business Overview
  40. 8.7.3 GE Healthcare Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 GE Healthcare Iodine Contrast Agent Intermediate Product Portfolio
  42. 8.7.5 GE Healthcare Recent Developments
  43. 8.8 Bracco Imaging
  44. 8.8.1 Bracco Imaging Company Information
  45. 8.8.2 Bracco Imaging Business Overview
  46. 8.8.3 Bracco Imaging Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bracco Imaging Iodine Contrast Agent Intermediate Product Portfolio
  48. 8.8.5 Bracco Imaging Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Iodine Contrast Agent Intermediate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Iodine Contrast Agent Intermediate Product Portfolio
  54. 8.9.5 Bayer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Iodine Contrast Agent Intermediate Value Chain Analysis
  2. 9.1.1 Iodine Contrast Agent Intermediate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Iodine Contrast Agent Intermediate Sales Mode & Process
  6. 9.2 Iodine Contrast Agent Intermediate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Iodine Contrast Agent Intermediate Distributors
  9. 9.2.3 Iodine Contrast Agent Intermediate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst